Psychedelics have come a long way from their pop culture reputation. Think Fear and Loathing in Las Vegas, Alice in Wonderland, and every movie scene where the walls suddenly start breathing. Psychedelics have moved from the counterculture into mainstream conversations about medicine, mental health, neuroscience, and public policy. Researchers are studying substances such as psilocybin and LSD, states are experimenting with new regulatory approaches, and Minnesota is exploring what a future therapeutic psilocybin program could look like.

But what exactly are psychedelics, how do they work, and what should people know about their potential benefits and risks?

What Are Psychedelics?

Psychedelics are psychoactive substances that can temporarily alter perception, mood, thinking, and a person’s sense of time and surroundings.

Classic psychedelics generally include:

• Psilocybin: The psychoactive compound found in certain species of mushrooms, commonly called magic mushrooms.
• LSD (lysergic acid diethylamide): A potent synthetic psychedelic known for its effects on perception and consciousness.
• Mescaline: A naturally occurring psychedelic found in certain species of cacti.
• DMT (dimethyltryptamine): A powerful psychedelic compound found naturally in some plants and also produced synthetically.

Other substances, including MDMA, ketamine, and ibogaine, are frequently discussed alongside psychedelics, although their pharmacology and effects differ from those of classic psychedelics.

Classic psychedelics interact with the brain’s serotonin system, particularly receptors known as 5-HT2A receptors. This interaction can temporarily change how the brain processes sensory information, emotions, and thoughts.

Commonly reported effects include:

• Intensified colors, sounds, and visual experiences.
• Changes in the perception of time.
• Heightened emotional sensitivity.
• Altered thought patterns and increased introspection.
• Changes in a person’s sense of self or connection to their surroundings.

The experience can vary significantly depending on the substance, individual, expectations, and environment.

Researchers often refer to the importance of “set and setting.” Set describes a person’s mindset and expectations, while setting refers to the physical and social environment. Both can substantially influence a psychedelic experience.

What Is Psilocybin?

Psilocybin has become one of the most prominent substances in modern psychedelic research.

After entering the body, psilocybin is converted into psilocin, the compound primarily responsible for its psychedelic effects.

Researchers have investigated psilocybin in connection with several mental-health conditions, including depression and substance use disorders.

Some clinical findings have been encouraging, but research remains ongoing. Important questions about long-term effectiveness, safety, and appropriate clinical use have not been fully resolved.

It is also important to distinguish promising research from established medical treatment.

Are Psychedelics Safe?

Although some research has identified potential therapeutic applications, these substances can also produce significant physical and psychological effects.

Potential adverse effects include:

• Anxiety, panic, or paranoia.
• Nausea and gastrointestinal discomfort.
• Increased heart rate and blood pressure.
• Confusion or impaired judgment.
• Distressing changes in perception.
• Rare but potentially serious psychiatric complications.

Are Psychedelics Legal in Minnesota?

Psilocybin and psilocin are controlled substances under Minnesota law and are not legal for general recreational use. However, Minnesota has been examining potential approaches to psychedelic regulation and therapeutic access.

The state has considered proposals involving supervised psilocybin services and the possible development of a regulated therapeutic program. These discussions involve questions about patient eligibility, safety standards, professional oversight, licensing, and access to treatment.

The Bottom Line

Scientific interest in psychedelics has expanded considerably after decades of restricted research.

Universities, medical institutions, and researchers are investigating whether certain psychedelic compounds could eventually play a role in treating serious mental-health conditions.

At the same time, policymakers are examining how to address public safety, medical access, professional standards, and criminal law.

These developments have created renewed public interest in understanding psychedelics beyond their historical association with recreational drug use.

For Minnesota residents, the conversation is particularly relevant as the state evaluates possible approaches to psychedelic therapies.

Psychedelics are powerful psychoactive substances with a complicated history and a growing body of scientific research.

MinnesotaPsychedelics is dedicated to providing accessible, evidence-based information about psychedelic research, education, and policy developments in Minnesota and beyond.

---

Sources

• National Institute on Drug Abuse (NIDA): https://nida.nih.gov/research-topics/psychedelic-dissociative-drugs
• U.S. Food and Drug Administration (FDA), Psychedelic Drugs: https://www.fda.gov/drugs/resources-drugs/psychedelic-drugs
• National Center for Complementary and Integrative Health, Psilocybin: https://www.nccih.nih.gov/health/psilocybin-for-mental-health-and-addiction-what-you-need-to-know
• Minnesota Statutes, Chapter 152: https://www.revisor.mn.gov/statutes/cite/152

Disclaimer: This article is provided for educational and informational purposes only. It does not constitute medical or legal advice. Laws and regulations are subject to change.